A new tactic is the USMCA, which under Article 20 F. 14 would grant at least a 10-year “test data” exclusivity period for new biologics. Currently, …
https://thehill.com/opinion/healthcare/449741-big-pharma-is-the-big-winner-of-the-usmca
Your Music and More ..